These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14586063)

  • 1. Detangling Alzheimer's disease. New insights into the biological bases of the most common cause of dementia are pointing to better diagnostics and possible therapeutics.
    Helmuth L
    Sci Aging Knowledge Environ; 2003 Oct; 2003(43):oa2. PubMed ID: 14586063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detangling Alzheimer's disease.
    Helmuth L
    Sci Aging Knowledge Environ; 2001 Oct; 2001(1):oa2. PubMed ID: 14602946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.
    Masters CL; Cappai R; Barnham KJ; Villemagne VL
    J Neurochem; 2006 Jun; 97(6):1700-25. PubMed ID: 16805778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease. Hope for the future.
    Morrison-Bogorad M
    Caring; 2002 Aug; 21(8):12-5. PubMed ID: 12739346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for Alzheimer's disease.
    Sonnen JA; Keene CD; Montine KS; Li G; Peskind ER; Zhang J; Montine TJ
    Expert Rev Neurother; 2007 Aug; 7(8):1021-8. PubMed ID: 17678497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
    Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
    Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dementia: a brief review.
    Grossman H; Bergmann C; Parker S
    Mt Sinai J Med; 2006 Nov; 73(7):985-92. PubMed ID: 17195884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
    Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing Alzheimer's dementia in Down syndrome: problems and possible solutions.
    Nieuwenhuis-Mark RE
    Res Dev Disabil; 2009; 30(5):827-38. PubMed ID: 19269132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2008 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2008 Mar; 4(2):110-33. PubMed ID: 18631956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2009 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2009 May; 5(3):234-70. PubMed ID: 19426951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of anti-Abeta vaccination as a promising therapy for Alzheimer's disease.
    Okura Y; Matsumoto Y
    Drug News Perspect; 2007; 20(6):379-86. PubMed ID: 17925892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivastigmine for Alzheimer's disease.
    Desai AK; Grossberg GT
    Expert Rev Neurother; 2005 Sep; 5(5):563-80. PubMed ID: 16162080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of Alzheimer's disease: population-based estimates and projections for New Zealand, 2006-2031.
    Tobias M; Yeh LC; Johnson E
    Aust N Z J Psychiatry; 2008 Sep; 42(9):828-36. PubMed ID: 18696288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in preclinical Alzheimer's disease.
    Chong MS; Lim WS; Sahadevan S
    Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A perspective on risks that impede development of drugs to modify the course of Alzheimer's disease: can they be reduced?
    Mohs RC
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S85-7. PubMed ID: 18632007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.
    MacDonald AB
    Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and protective factors for sporadic Alzheimer's disease.
    Stozická Z; Zilka N; Novák M
    Acta Virol; 2007; 51(4):205-22. PubMed ID: 18197729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
    Relkin NR
    Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.